Shire Plc (SHP)

Sector: Pharma and Biotech     Index: FTSE 100
-2.21%
-83.00p
3,677.50p
16:59 13/12/17
3,677.50p
16:59 13/12/17
DAILY VARIATION
-2.21%
-83.00p
VOLUME
2,158,327
REAL TIME BATS
3,684.50p
16:30 13/12/17
-2.10%
-79.00p
DATA
52 Week High
5,036.00p
52 Week Low
3,499.00p
Shares Issued
909.58m
Market Cap
£33,449.89m
RiskGrade
n/a
Beta
1.25
MENU

Shire Plc Overview

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

slide to see more

Key Personnel

slide to see more
CEO: Flemming Ornskov
CFO: Jeff Poulton
Chairman: Susan Kilsby
Non-Executive Director: Albert P.L. Stroucken , Ian Clark, Steven Gillis, David Ginsburg, Sara Mathew, Anne Minto, Dominic Blakemore , Gail D. Fosler
Senior Independent Director: William Burns
Deputy Company Secretary: Stephen Williams
Non-Executive Director and Company Secretary: Olivier Bohuon

Contact Details

slide to see more
Address: 22 Grenville Street, St Helier, Jersey
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: http://www.shire.com
Email:

Listings